Michele Ghielmini, M.D.

Prof. Michele Ghielmini is Head of the Oncology Department at the Oncology Institute of Southern Switzerland, where he also leads the autologous stem cell transplantation program. He is Professor of Medicine at the University of Bern, Switzerland and member of the Lymphoma Section of the Swiss Group for Clinical Cancer Research (SAKK) which he has chaired for many years. Dr. Ghielmini originally studied medicine in Lausanne and Zurich, followed by post-graduate training in Bern and a research fellowship at the Christie Cancer Centre, Manchester, UK, and the University Hospital of Frankfurt, Germany.

As an expert in the treatment of malignant lymphoma, Dr. Ghielmini was an editorial board member for Annals of Oncology for many years and he is now on the editorial board for Journal of Clinical Oncology. Dr. Ghielmini has authored many publications mainly in the field of haemato-toxicology, autologous stem cell transplantation and treatment of lymphoma. His recent clinical research has focused on the treatment of lymphoma with monoclonal antibodies.

Click here for Dr. Ghielmini's profile and contact information.

Click this link for WM clinical trials under Dr. Ghielmini.